HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gregory C Rogers Selected Research

Glucose Transporter Type 3

3/2022GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gregory C Rogers Research Topics

Disease

6Neoplasms (Cancer)
03/2022 - 10/2011
1Hypoxia (Hypoxemia)
03/2022
1Tetraploidy
01/2020
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2020
1Prostatic Intraepithelial Neoplasia
01/2017
1Genomic Instability
01/2017
1Laminopathies
12/2014
1Type II Microcephalic Osteodysplastic Primordial Dwarfism
09/2014
1Inborn Genetic Diseases (Disease, Hereditary)
09/2014
1Aneuploidy (Aneuploid)
10/2010
1Wounds and Injuries (Trauma)
06/2010

Drug/Important Bio-Agent (IBA)

1Biomarkers (Surrogate Marker)IBA
03/2022
1AntibodiesIBA
03/2022
1Oxygen (Dioxygen)IBA
03/2022
1Glucose Transporter Type 3IBA
03/2022
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
03/2022
1Antineoplastic Agents (Antineoplastics)IBA
01/2020
1Pharmaceutical PreparationsIBA
01/2020
1LigandsIBA
01/2017
1Phenobarbital (Luminal)FDA Link
01/2017
1IntegrinsIBA
01/2017
1ChromatinIBA
12/2014
1pericentrinIBA
09/2014
1Neoplasm Antigens (Tumor Antigens)IBA
10/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2010
1Proteins (Proteins, Gene)FDA Link
06/2010

Therapy/Procedure

2Therapeutics
10/2019 - 01/2019